247 related articles for article (PubMed ID: 33867835)
1. Paradoxical HBsAg and anti-HBs coexistence among Chronic HBV Infections: Causes and Consequences.
Jiang X; Chang L; Yan Y; Wang L
Int J Biol Sci; 2021; 17(4):1125-1137. PubMed ID: 33867835
[TBL] [Abstract][Full Text] [Related]
2. Coexistence of hepatitis B surface antigen (HBsAg) and heterologous subtype-specific antibodies to HBsAg among patients with chronic hepatitis B virus infection.
Zhang JM; Xu Y; Wang XY; Yin YK; Wu XH; Weng XH; Lu M
Clin Infect Dis; 2007 May; 44(9):1161-9. PubMed ID: 17407033
[TBL] [Abstract][Full Text] [Related]
3. Coexistence of hepatitis B surface antigen and antibody to hepatitis B surface may increase the risk of hepatocellular carcinoma in chronic hepatitis B virus infection: a retrospective cohort study.
Seo SI; Choi HS; Choi BY; Kim HS; Kim HY; Jang MK
J Med Virol; 2014 Jan; 86(1):124-30. PubMed ID: 24127328
[TBL] [Abstract][Full Text] [Related]
4. Coexistence of low levels of HBsAg and high levels of anti-HBs may increase risk of hepatocellular carcinoma in chronic hepatitis B patients with high HBV load.
Jin ZZ; Jin FF; Liu X; Liu N; Wen F; Lou JL
Braz J Infect Dis; 2019; 23(5):343-351. PubMed ID: 31542378
[TBL] [Abstract][Full Text] [Related]
5. Development of anti-hepatitis B surface (HBs) antibodies after HBs antigen loss in HIV-hepatitis B virus co-infected patients.
Boyd A; Canini L; Gozlan J; Lascoux-Combe C; Miailhes P; Fonquernie L; Girard PM; Lacombe K
J Clin Virol; 2017 Oct; 95():55-60. PubMed ID: 28869890
[TBL] [Abstract][Full Text] [Related]
6. Association of concurrent hepatitis B surface antigen and antibody to hepatitis B surface antigen with hepatocellular carcinoma in chronic hepatitis B virus infection.
Jang JS; Kim HS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Kim DJ; Lee MS; Park CK; Jeong BH; Kim YS; Jang MK
J Med Virol; 2009 Sep; 81(9):1531-8. PubMed ID: 19623669
[TBL] [Abstract][Full Text] [Related]
7. Clinical and Virological Characteristics of Chronic Hepatitis B Patients with Coexistence of HBsAg and Anti-HBs.
Liu Y; Zhang L; Zhou JY; Pan J; Hu W; Zhou YH
PLoS One; 2016; 11(1):e0146980. PubMed ID: 26751075
[TBL] [Abstract][Full Text] [Related]
8. Mutation in the S gene of hepatitis B virus and anti-HBs subtype-nonspecificity contributed to the co-existence of HBsAg and anti-HBs in patients with chronic hepatitis B virus infection.
Fu X; Chen J; Chen H; Lin J; Xun Z; Li S; Liu C; Zeng Y; Chen T; Yang B; Ou Q
J Med Virol; 2017 Aug; 89(8):1419-1426. PubMed ID: 28198078
[TBL] [Abstract][Full Text] [Related]
9. [Atypical serological profiles in hepatitis B infections: investigation of S gene mutations in cases with concurrently positive for HBsAg and anti-HBs].
Aydın N; Kırdar S; Uzun N; Eyigör M; Sayan M
Mikrobiyol Bul; 2016 Oct; 50(4):535-543. PubMed ID: 28124958
[TBL] [Abstract][Full Text] [Related]
10. Clinical and virological characteristics of coexistent hepatitis B surface antigen and antibody in treatment-naive children with chronic hepatitis B virus infection.
Xu Y; Li S; OuYang W; Yao Z; Lai X; Gu Y; Yang M; Ye L; Li S; Peng S
Front Public Health; 2024; 12():1380771. PubMed ID: 38952725
[TBL] [Abstract][Full Text] [Related]
11. Nationwide seroepidemiology of hepatitis B virus infection in South Korea in 2009 emphasizes the coexistence of HBsAg and anti-HBs.
Lee BS; Cho YK; Jeong SH; Lee JH; Lee D; Park NH; Ki M;
J Med Virol; 2013 Aug; 85(8):1327-33. PubMed ID: 23723057
[TBL] [Abstract][Full Text] [Related]
12. Epidemiological characteristics of the carriers with coexistence of HBsAg and anti-HBs based on a community cohort study.
Pu Z; Li D; Wang A; Su H; Shao Z; Zhang J; Ji Z; Gao J; Choi BC; Yan Y
J Viral Hepat; 2016 Apr; 23(4):286-93. PubMed ID: 26663578
[TBL] [Abstract][Full Text] [Related]
13. Identified OAS3 gene variants associated with coexistence of HBsAg and anti-HBs in chronic HBV infection.
Wang S; Wang J; Fan MJ; Li TY; Pan H; Wang X; Liu HK; Lin QF; Zhang JG; Guan LP; Zhernakova DV; O'Brien SJ; Feng ZR; Chang L; Dai EH; Lu JH; Xi HL; Zeng Z; Yu YY; Wang BB
J Viral Hepat; 2018 Aug; 25(8):904-910. PubMed ID: 29582521
[TBL] [Abstract][Full Text] [Related]
14. Elimination of hepatitis B virus surface antigen and appearance of neutralizing antibodies in chronically infected patients without viral clearance.
Zhang ZH; Li L; Zhao XP; Glebe D; Bremer CM; Zhang ZM; Tian YJ; Wang BJ; Yang Y; Gerlich W; Roggendorf M; Li X; Lu M; Yang DL
J Viral Hepat; 2011 Jun; 18(6):424-33. PubMed ID: 20819150
[TBL] [Abstract][Full Text] [Related]
15. Mutations in hepatitis B virus DNA from patients with coexisting HBsAg and anti-HBs.
Chen Y; Qian F; Yuan Q; Li X; Wu W; Guo X; Li L
J Clin Virol; 2011 Nov; 52(3):198-203. PubMed ID: 21840251
[TBL] [Abstract][Full Text] [Related]
16. Coexistence of hepatitis B surface antigen and anti-HBs in Chinese chronic hepatitis B virus patients relating to genotype C and mutations in the S and P gene reverse transcriptase region.
Liu W; Hu T; Wang X; Chen Y; Huang M; Yuan C; Guan M
Arch Virol; 2012 Apr; 157(4):627-34. PubMed ID: 22222283
[TBL] [Abstract][Full Text] [Related]
17. Mutations in the S gene and in the overlapping reverse transcriptase region in chronic hepatitis B Chinese patients with coexistence of HBsAg and anti-HBs.
Ding F; Miao XL; Li YX; Dai JF; Yu HG
Braz J Infect Dis; 2016; 20(1):1-7. PubMed ID: 26613893
[TBL] [Abstract][Full Text] [Related]
18. Sequence analysis of the HBV S protein in Chinese patients with coexisting HBsAg and anti-HBs antibodies.
Ding F; Yu HG; Li YX; Cui N; Dai JF; Yu JP
J Med Virol; 2015 Dec; 87(12):2067-73. PubMed ID: 26010146
[TBL] [Abstract][Full Text] [Related]
19. PreS deletion mutations of hepatitis B virus in chronically infected patients with simultaneous seropositivity for hepatitis-B surface antigen and anti-HBS antibodies.
Huang X; Qin Y; Zhang P; Tang G; Shi Q; Xu J; Qi F; Shen Q
J Med Virol; 2010 Jan; 82(1):23-31. PubMed ID: 19950231
[TBL] [Abstract][Full Text] [Related]
20. Molecular and serological characterization of hepatitis B vaccine breakthrough infections in serial samples from two plasma donors.
Kuhns MC; McNamara AL; Holzmayer V; Cloherty GA
Virol J; 2019 Apr; 16(1):43. PubMed ID: 30943997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
